These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 17651896)

  • 1. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens.
    Ramamoorthy S; Sanakkayala N; Vemulapalli R; Jain N; Lindsay DS; Schurig GS; Boyle SM; Sriranganathan N
    Int J Parasitol; 2007 Nov; 37(13):1531-8. PubMed ID: 17575983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens.
    Ramamoorthy S; Sanakkayala N; Vemulapalli R; Duncan RB; Lindsay DS; Schurig GS; Boyle SM; Kasimanickam R; Sriranganathan N
    Int J Parasitol; 2007 Nov; 37(13):1521-9. PubMed ID: 17568587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations.
    Pinitkiatisakul S; Friedman M; Wikman M; Mattsson JG; Lövgren-Bengtsson K; Ståhl S; Lundén A
    Vaccine; 2007 May; 25(18):3658-68. PubMed ID: 17280751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice.
    Haldorson GJ; Mathison BA; Wenberg K; Conrad PA; Dubey JP; Trees AJ; Yamane I; Baszler TV
    Int J Parasitol; 2005 Nov; 35(13):1407-15. PubMed ID: 16051244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
    Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
    J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
    Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Jiménez-Ruíz E; Alvarez-García G
    Vaccine; 2011 Oct; 29(44):7867-74. PubMed ID: 21816191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
    Srinivasan S; Mueller J; Suana A; Hemphill A
    J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Hemphill A
    Parasitology; 2010 Feb; 137(2):229-40. PubMed ID: 19835644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model).
    Ellis J; Miller C; Quinn H; Ryce C; Reichel MP
    Vaccine; 2008 Nov; 26(47):5989-96. PubMed ID: 18789996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
    Alaeddine F; Keller N; Leepin A; Hemphill A
    J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice.
    Aguado-Martínez A; Alvarez-García G; Fernández-García A; Risco-Castillo V; Marugán-Hernández V; Ortega-Mora LM
    Vaccine; 2009 Dec; 27(52):7331-8. PubMed ID: 19782735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
    Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
    J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.
    Monney T; Rütti D; Schorer M; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2011 Sep; 29(40):6967-75. PubMed ID: 21787824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
    Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum.
    Bartley PM; Wright S; Chianini F; Buxton D; Innes EA
    Parasitology; 2008 Jan; 135(Pt 1):13-21. PubMed ID: 17767798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum.
    Liddell S; Parker C; Vinyard B; Jenkins M; Dubey JP
    J Parasitol; 2003 Jun; 89(3):496-500. PubMed ID: 12880248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
    Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
    Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification and antigenicity of Neospora caninum-antigens using silkworm larvae targeting for subunit vaccines.
    Otsuki T; Dong J; Kato T; Park EY
    Vet Parasitol; 2013 Feb; 192(1-3):284-7. PubMed ID: 23102762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.